PillRx only · Patch, Extended Release · Transdermal
Rivastigmine
Brands: Exelon · Rivastigmine
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US28 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 17 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$8.916
Latest avg · Jul 22, 2026
-59%
Since Sep 17, 2025
6
Active US suppliers
56%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.7K
Rx · 2026 Q1
90K
Units dispensed
+11%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 8 | SUPPLYING |
| Sandoz Inc | unknown | 6 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 3 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 3 | SUPPLYING |
| Breckenridge Pharmaceutical, Inc. | unknown | 3 | SUPPLYING |
| NorthStar Rx LLC | unknown | 2 | SUPPLYING |
| Novartis Pharmaceuticals Corporation | unknown | 3 | EXITED 2026 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.